Long-Acting, Potent Delivery of Combination Antiretroviral Therapy.
ACS Macro Lett
; 7(5): 587-591, 2018 May 15.
Article
em En
| MEDLINE
| ID: mdl-35632936
ABSTRACT
Antiretroviral therapy (ART) has revolutionized HIV treatment, yet grand challenges remain (i) short blood and body residence time of the antiviral drugs, (ii) relative poor antiretroviral drug penetrance into key tissue reservoirs of viral infection, namely, the spleen and lymph nodes, and (iii) obstacles in different pharmacokinetics of the necessary combination drugs. We present a novel drug delivery approach that simultaneously overcomes these limitations. We designed albumin-polymer-drug conjugates where albumin ensures long body residence time as well as lymphatic accumulation of the conjugate. The polymer enabled the delivery of combinations of drugs in precise ratios affording potency superior to the individual antiretroviral drugs and strong protection from HIV infection in primary human T cells.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
ACS Macro Lett
Ano de publicação:
2018
Tipo de documento:
Article